Tag results:
mammary cells
Mammary Cell News
A New α-Pyrone from Arthrinium pseudosinense Culture Medium and Its Estrogenic Activity in MCF-7 Cells
[Journal of Antibiotics] Arthrifuranone A was isolation from an EtOAc-extract of Arthrinium pseudosinense culture medium and evaluated for its estrogenic activity using the MCF-7 estrogen responsive human breast cancer cells.
Mammary Cell News
gp130 Cytokines Activate Novel Signaling Pathways and Alter Bone Dissemination in ER+ Breast Cancer Cells
[Journal of Bone and Mineral Research] In estrogen receptor positive (ER+) cells, oncostatin M (OSM) robustly stimulated phosphorylation of known gp130 signaling targets STAT3, ERK and AKT, while CNTF activated STAT3 signaling. In ER- breast cancer cells, OSM alone stimulated AKT and ERK signaling.
Mammary Cell News
SHOX2 Cooperates with STAT3 to Promote Breast Cancer Metastasis through the Transcriptional Activation of WASF3
[Journal of Experimental & Clinical Cancer Research] TCGA analysis was performed to identify the clinical relevance of short stature homeobox 2 (SHOX2) in breast cancer. Molecular regulations and alterations were assessed by Western blotting, immunoprecipitation, immunohistochemistry, qRT-PCR, chromatin immunoprecipitation coupled with qPCR, and ChIP/re-ChIP.
Mammary Cell News
SNP rs4971059 Predisposes to Breast Carcinogenesis and Chemoresistance via TRIM46-Mediated HDAC1 Degradation
[EMBO Journal] Scientists reported that the single nucleotide polymorphism (SNP) rs4971059, one of 65 new breast cancer risk loci identified in a recent genome-wide association study, functioned as an active enhancer of TRIM46 expression. TRIM46 promoted breast cancer cell proliferation and chemoresistance in vitro and accelerated tumor growth in vivo.
Cancer Stem Cell News
Adipose-Derived Stem/Stromal Cell Secretome Modulates Breast Cancer Cell Proliferation and Differentiation State towards Aggressiveness
[Biochimie] To understand the role of the adipose-derived stem cell secretome in breast cancer cell proliferation, death, and phenotype alteration, adipose-derived stem cell-conditioned medium was used to cultivate MCF-7 and MDA-MB-231 cells.
Cancer Stem Cell News
AKT Inhibitor AZD5363 Suppresses Stemness and Promotes Anti-Cancer Activity of 3,3′-Diindolylmethane in Human Breast Cancer Cells
[Toxicology and Applied Pharmacology] Investigators observed that proportion of CD133+Nanog+ subpopulation in MCF-7 cells was significantly increased after 3,3′-diindolylmethane administration with up-regulated AKT activity by using CyTOF assay.